Objective To investigate whether baseline olfactory dysfunction in Parkinson’s disease (PD) patients is associated with baseline and longitudinal motor and cognitive function.
Methods We recruited 228 drug-naïve PD patients who were followed for a mean of 6 years. Patients underwent the Cross-Cultural Smell Identification Test (CCSIT), a neuropsychological test, and N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane positron emission tomography within 6 months of the baseline evaluation. Olfactory dysfunction was categorized as normosmia (CCSIT score ≥ 9), hyposmia (CCSIT score 5–8), and anosmia (CCSIT score ≤ 4). During the follow-up period, we investigated changes in the levodopa-equivalent dose (LED) and the occurrence of wearing-off, levodopa-induced dyskinesia, and dementia.
Results Among the PD patients, 80.7% were hyposmic at the time of diagnosis, and 26.1% were anosmic. Baseline olfactory dysfunction was not associated with either initial parkinsonian motor symptoms or with the longitudinal LED increment and motor complications. Meanwhile, the anosmic group had lower baseline scores on the Korea version of the Boston Naming Test and Stroop color reading test than the normosmic and hyposmic groups. The anosmic group exhibited a higher rate of conversion to dementia than the normosmic [adjusted hazard ratio (HR) 3.99, 95% confidence interval (CI) 1.08–14.72] and hyposmic (adjusted HR 2.48, 95% CI 1.15–5.32) PD groups, regardless of baseline motor deficits and cognitive status.
Conclusion Baseline olfactory dysfunction was not associated with motor deficits and complications, but it was associated with cognitive dysfunction and prognosis, suggesting that severe olfactory impairment may reflect early cortical involvement, probably in the frontotemporal region, and rapid spreading of Lewy body pathology.
Citations
Citations to this article as recorded by
Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson’s disease Min Seung Kim, Don Gueu Park, In Ja Shin, Young Sil An, Jung Han Yoon Journal of Neurology.2025;[Epub] CrossRef
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review Nicolas De Cleene, Katarína Schwarzová, Samuel Labrecque, Clancy Cerejo, Atbin Djamshidian, Klaus Seppi, Beatrice Heim Frontiers in Neuroscience.2025;[Epub] CrossRef
Clinical Predictors of Freezing of Gait in Patients with Parkinson's Disease: A Systematic Review Sohaila Alshimemeri, Abdulrahman alhayssoni, Reema Hazazi Clinical Neurology and Neurosurgery.2025; : 108848. CrossRef
Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson’s disease Mehrdad Mozafar, Zobeydeh Dehghan Manshadi, Zohreh Molaei, Hedye Babaei, Meysam Mansouri, Sahba Shahbazi, Shayan Shakeri, Hanieh Mirhosseini, David Gulisashvili, Mahsa Mayeli Clinical Neurology and Neurosurgery.2025; 251: 108817. CrossRef
Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson’s disease Dong-Woo Ryu, Sang-Won Yoo, Ko-Eun Choi, Yoon-Sang Oh, Joong-Seok Kim Journal of Neurology.2024; 271(3): 1397. CrossRef
Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease Sang-Won Yoo, Dong-Woo Ryu, Yoon-Sang Oh, Seunggyun Ha, Chul Hyoung Lyoo, Yuna Kim, Ji-Yeon Yoo, Joong-Seok Kim Journal of Neurology.2024; 271(4): 2019. CrossRef
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype? So Hoon Yoon, Dae Hyuk You, Han Kyu Na, Sungwoo Kang, Kyoungwon Baik, Mincheol Park, Chul Hyoung Lyoo, Young H. Sohn, Phil Hyu Lee Journal of Neurology.2024; 271(8): 5064. CrossRef
Unraveling olfactory subtypes in Parkinson’s disease and their effect on the natural history of the disease Sang-Won Yoo, Dong-Woo Ryu, Yoonsang Oh, Seunggyun Ha, Chul Hyoung Lyoo, Joong-Seok Kim Journal of Neurology.2024; 271(9): 6102. CrossRef
Determination of objective taste perception among Iranian medical sciences students during COVID‑19 pandemic in Yazd, Eastern Iran: a case-control pilot study Samira Hajimaghsoodi, Elham Paydar, Fatemeh Owlia BMC Infectious Diseases.2024;[Epub] CrossRef
Olfactory Dysfunction in Parkinson’s Disease, Its Functional and Neuroanatomical Correlates Gabriel Torres-Pasillas, Donají Chi-Castañeda, Porfirio Carrillo-Castilla, Gerardo Marín, María Elena Hernández-Aguilar, Gonzalo Emiliano Aranda-Abreu, Jorge Manzo, Luis I. García NeuroSci.2023; 4(2): 134. CrossRef
Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses G. Brand, C. Bontempi, L. Jacquot Revue Neurologique.2023; 179(9): 947. CrossRef
Sequential change in olfaction and (non) motor symptoms: the difference between anosmia and non-anosmia in Parkinson’s disease Ting-Chun Fang, Yu-Shan Tsai, Ming-Hong Chang Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
Traumatic brain injury-induced inflammatory changes in the olfactory bulb disrupt neuronal networks leading to olfactory dysfunction Xiang Liu, Zhuofan Lei, Dylan Gilhooly, Junyun He, Yun Li, Rodney M. Ritzel, Hui Li, Long-Jun Wu, Shaolin Liu, Junfang Wu Brain, Behavior, and Immunity.2023; 114: 22. CrossRef
Serum Biomarkers of Olfactory Identification Deficits in Patients with Parkinson’s Disease Fu-Jia Li, Yang-Dan-Yu Li, Xu Liu, Jie Zu, Wei Zhang, Qi-Hua Xiao, Xue-Bin Niu, Li Du, Chen-Chen Cui, Ru-Yu Zhang, Xiao-Qing He, Gui-Yun Cui, Chuan-Ying Xu, Dominic B. Fee Acta Neurologica Scandinavica.2023; 2023: 1. CrossRef
UPSIT subitems may predict motor progression in Parkinson’s disease Yu-Hsuan Lin, Ting-Chun Fang, Hsin-Bei Lei, Shih-Chi Chiu, Ming-Hong Chang, Yi-Jen Guo Frontiers in Neurology.2023;[Epub] CrossRef
Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease Fardin Nabizadeh, Kasra Pirahesh, Elham Khalili Neurological Sciences.2022; 43(7): 4193. CrossRef
Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial Jaewon Kim, Dong Keon Yon, Kyu Yeong Choi, Jang Jae Lee, Namwoo Kim, Kun Ho Lee, Jae Gwan Kim Alzheimer's Research & Therapy.2022;[Epub] CrossRef
The Role of Olfactory System in the Etiogenesis of Parkinson’s Diseases: An Overview Jiju Narayanan Avanipully, Dithu Thekkekkara, Sahyadri M, Vipan K. Parihar, Santhepete Nanjundaiah Manjula Journal of Pharmacology and Pharmacotherapeutics.2022; 13(1): 31. CrossRef
International consensus statement on allergy and rhinology: Olfaction Zara M. Patel, Eric H. Holbrook, Justin H. Turner, Nithin D. Adappa, Mark W. Albers, Aytug Altundag, Simone Appenzeller, Richard M. Costanzo, Ilona Croy, Greg E. Davis, Puya Dehgani‐Mobaraki, Richard L. Doty, Valerie B. Duffy, Bradley J. Goldstein, David International Forum of Allergy & Rhinology.2022; 12(4): 327. CrossRef
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature Tommaso Ercoli, Carla Masala, Gianluca Cadeddu, Marcello Mario Mascia, Gianni Orofino, Angelo Fabio Gigante, Paolo Solla, Giovanni Defazio, Lorenzo Rocchi Brain Sciences.2022; 12(5): 513. CrossRef
Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease Fardin Nabizadeh, Fatemeh Sodeifian, Kasra Pirahesh Neurological Sciences.2022; 43(8): 4745. CrossRef
Olfaction and Executive Cognitive Performance: A Systematic Review Vasudeva Murthy Challakere Ramaswamy, Peter William Schofield Frontiers in Psychology.2022;[Epub] CrossRef
Nasal and Parotid Blood Pool Activity Is Significantly Correlated with Metabolic Syndrome Components and Sleep Apnea William T. Phillips, Nasser J. Issa, Shereef B. Elhalwagi, Hilda T. Draeger, Joyce G. Schwartz, Jonathan A. Gelfond Metabolic Syndrome and Related Disorders.2022; 20(7): 395. CrossRef
Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium Gabriel A. de Erausquin, Heather Snyder, Traolach S. Brugha, Sudha Seshadri, Maria Carrillo, Rajesh Sagar, Yueqin Huang, Charles Newton, Carmela Tartaglia, Charlotte Teunissen, Krister Håkanson, Rufus Akinyemi, Kameshwar Prasad, Giovanni D'Avossa, Gabriel Alzheimer's & Dementia: Translational Research & Clinical Interventions.2022;[Epub] CrossRef
Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease Joshua Harvey, Rick A. Reijnders, Rachel Cavill, Annelien Duits, Sebastian Köhler, Lars Eijssen, Bart P. F. Rutten, Gemma Shireby, Ali Torkamani, Byron Creese, Albert F. G. Leentjens, Katie Lunnon, Ehsan Pishva npj Parkinson's Disease.2022;[Epub] CrossRef
Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota Chao Li, Ying Hou, Xu Wang, Yue-xuan Li, Feng Li, Chao Zhang, Wei-guo Li Frontiers in Neurology.2021;[Epub] CrossRef
Hyposmia may predict development of freezing of gait in Parkinson’s disease Jae Jung Lee, Jin Yong Hong, Jong Sam Baik Journal of Neural Transmission.2021; 128(6): 763. CrossRef
Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson’s Disease Han Soo Yoo, Sangwon Lee, Seong Ho Jeong, Byoung Seok Ye, Young H. Sohn, Mijin Yun, Phil Hyu Lee Journal of Parkinson's Disease.2021; 11(4): 1703. CrossRef